• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mucosal Immunol . Determination of Tr1 cell populations correlating with distinct activation states in acute IAV infection

tetano

Editor, Senior Moderator
Mucosal Immunol


. 2023 Jun 13;S1933-0219(23)00048-X.
doi: 10.1016/j.mucimm.2023.06.003. Online ahead of print. Determination of Tr1 cell populations correlating with distinct activation states in acute IAV infection

Caitlin A Abbott[SUP] 1 [/SUP], Emily L Freimayer[SUP] 2 [/SUP], Timona S Tyllis[SUP] 3 [/SUP], Todd S Norton[SUP] 4 [/SUP], Mohammed Alsharifi[SUP] 5 [/SUP], Aaron H S Heng[SUP] 6 [/SUP], Stephen M Pederson[SUP] 7 [/SUP], Zhipeng Qu[SUP] 8 [/SUP], Mark Armstrong[SUP] 9 [/SUP], Geoffrey R Hill[SUP] 10 [/SUP], Shaun R McColl[SUP] 11 [/SUP], Iain Comerford[SUP] 12 [/SUP]



Affiliations
Abstract

Type I regulatory (Tr1) cells are defined as FOXP3[SUP]-[/SUP]IL-10-secreting CD4[SUP]+[/SUP] T cells that contribute to immune suppression and typically express the markers LAG-3 and CD49b and other co-inhibitory receptors. These cells have not been studied in detail the context of the resolution of acute infection in the lung. Here, we identify FOXP3[SUP]-[/SUP]IL-10[SUP]+[/SUP] CD4[SUP]+[/SUP] T cells transiently accumulating in the lung parenchyma during resolution of the response to sublethal influenza A virus (IAV) infection in mice. These cells were dependent on IL-27Rα, which was required for timely recovery from IAV-induced weight loss. LAG-3 and CD49b were not generally co-expressed by FOXP3[SUP]-[/SUP] IL-10[SUP]+[/SUP] CD4[SUP]+[/SUP] T cells in this model and four populations of these cells based on LAG-3 and CD49b co-expression were apparent (LAG-3[SUP]-[/SUP]CD49b[SUP]-[/SUP] [DN], LAG-3[SUP]+[/SUP]CD49b[SUP]+[/SUP] [DP], LAG-3[SUP]+[/SUP]CD49b[SUP]-[/SUP] [LAG-3[SUP]+[/SUP]], LAG-3[SUP]-[/SUP]CD49b[SUP]+[/SUP] [CD49b[SUP]+[/SUP]]). However, each population exhibited suppressive potential consistent with the definition of Tr1 cells. Notably, differences between these populations of Tr1 cells were apparent including differential dependence on IL-10 to mediate suppression and expression of markers indicative of different activation states and terminal differentiation. Sort-transfer experiments indicated that LAG-3[SUP]+[/SUP] Tr1 cells exhibited the capacity to convert to DN and DP Tr1 cells, indicative of plasticity between these populations. Together, these data determine the features and suppressive potential of Tr1 cells in the resolution of IAV infection and identify four populations delineated by LAG-3 and CD49b, which likely correspond to different Tr1 cell activation states.

Keywords: Influenza A virus; T cells; Type I regulatory T cells; pulmonary infection; regulatory T cells.

 
Back
Top Bottom